UVB and Psoriasis: More Than Immunosuppression
UVB's benefits may run deeper than inflammation suppression—cholesterol metabolism could be a key link.
-
By
-
Kerri Miller
-
April 6, 2026
-
Clinical Scorecard: UVB and Psoriasis: More Than Immunosuppression
At a Glance
| Category | Detail |
|---|
| Condition | Psoriasis |
| Key Mechanisms | Cholesterol synthesis, ROR-gamma signaling, IL-17 regulation |
| Target Population | Patients with psoriasis |
| Care Setting | Dermatology |
Key Highlights
- UVB phototherapy may disrupt cholesterol synthesis and ROR-gamma signaling.
- Cholesterol precursors can be converted into vitamin D3 and derivatives that inhibit inflammation.
- Proposed mechanisms suggest anti-inflammatory effects beyond immunosuppression.
- Noncalcemic vitamin D metabolites are potential therapeutic candidates.
- Further validation of lumisterol and tachysterol derivatives is needed.
Guideline-Based Recommendations
Diagnosis
- Consider psoriasis in patients with inflammatory skin lesions.
Management
- Utilize UVB phototherapy as a treatment option for psoriasis.
Monitoring & Follow-up
- Assess patient response to UVB therapy and adjust as necessary.
Risks
- Monitor for potential side effects of UVB exposure and vitamin D metabolites.
Patient & Prescribing Data
Individuals diagnosed with psoriasis.
Emerging therapies may target cholesterol metabolism and ROR-gamma signaling.
Clinical Best Practices
- Incorporate UVB phototherapy in treatment plans for psoriasis.
- Evaluate the role of cholesterol metabolism in psoriatic inflammation.
- Consider noncalcemic vitamin D derivatives in therapeutic strategies.
References
